• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Healthcare Disparity Efforts: Some Doubts, Stronger Incentives Needed | Managed Healthcare Executive® State of the Industry Survey

Publication
Article
MHE PublicationMHE January 2023
Volume 33
Issue 1

Survey shows some support but also some doubt about how effective the efforts will be. A sizable minority (43%) of respondents indicated that they believe stronger incentives are needed.

The combination of the uneven effects of COVID-19 pandemic and the killing of George Floyd put a spotlight on healthcare disparities in 2020. Almost every organization in U.S. healthcare rushed to address the issue in some way.

Responses to the Managed Healthcare Executive® annual State of the Survey showed support for the efforts. Only a small minority (13%) of the 450 respondents indicated that they agreed with the statement that the “underlying causes are too fundamental for healthcare to take on” and more than one-third (36%) agreed that addressing healthcare disparities is a good investment in dealing with the causes of health and illness.

However, the survey also revealed some doubts and belief that changes are needed. Nearlyhalf (47%) of the respondents indicated that they agree that efforts to address healthcare disparities are “well intentioned but unlikely to have a substantial effect.”A slightly smaller proportion (43%) said that financial incentives need to be strong to make them effective.

Related Videos
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Video 8 - "Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization"
Video 7 - "Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider"
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
© 2024 MJH Life Sciences

All rights reserved.